Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observation vs terazosin for distal ureter stone
KCT0005052Phase 4Not yet recruiting
- Sponsor
- Il-Yang Pharmaceutical
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terazosin in ureterolithiasis, sponsored by Il-Yang Pharmaceutical. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
terazosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on KCT0005052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005052.